Studies have shown that CTSG down-regulation was observed in AML patients, and its targeting and inhibition may offer a way for leukemia cells to elude cellular surveillance systems by inhibiting the breakdown of foreign proteins [36], and consistent with our research findings. This evidence concerns the gene CTSG and leukemia.